NAVB - Navidea Biopharmaceuticals Inc
Previous close
0.001
0 0%
Share volume: 1,836,193
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
Summary score
37%
Profitability
50%
Dept financing
25%
Liquidity
23%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2018 - 30-Jun-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
99.92%
Return on assets
-49.97%
Return on sales
-2504.39%
Return on invested capital
105.28%
Total debt ratio
107.67%
Debt ratio change over timeo
0.11%
Current Ratio
1.26%
Quick Ratio
1.24%
Cash Position Ratio
0.87%
Short-term ratios 30-Jun-2021 - 30-Jun-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
886.59%
Return on assets
-70.31%
Return on sales
-4940.46%
Return on invested capital
83.84%
Total debt ratio
152.84%
Debt ratio change over timeo
0.9%
Current Ratio
0.89%
Quick Ratio
0.85%
Cash Position Ratio
0.72%
Last quarter ratios 30-Jun-2022
The data are presented for the financials results of the last quarter.
Return on equity
66.17%
Return on assets
-116.73%
Return on sales
-5080.49%
Return on invested capital
75.19%
Total debt ratio
281.06%
Debt ratio change over time
2.74%
Current Ratio
0.22%
Quick Ratio
0.16%
Cash Position Ratio
0.06%
Performance ratios (change over 4 years) 30-Jun-2018 - 30-Jun-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
29.2%
Return on assets
-151.54%
Return on sales
-2616.56%
Return on invested capital
-1.43%
Total debt ratio
11.2%
Debt ratio change over time
0.11%
Current Ratio
0.15%
Quick Ratio
0.13%
Cash Position Ratio
-0.21%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NAVB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 99.92% | -5.26% | 29.03% | 8.2% |
| Return on assets | -49.97% | 3.1% | 3.72% | 6.13% |
| Return on sales | -2504.39% | 29.5% | 37.95% | 40.14% |
| Return on invested capital | 105.28% | 4.18% | 7.5% | 21.19% |
| Profitability | 50% | 32% | 48% | 57% |
| Total debt ratio | 107.67% | 99.44% | 85.54% | 28.23% |
| Debt ratio change over time | 0.11% | 269.43% | 13.18% | 1.21% |
| Dept financing | 25% | 48% | 21% | 7% |
| Current Ratio | 0.89% | 0.87% | 1.55% | 4.29% |
| Quick Ratio | 0.85% | 0.77% | 1.22% | 3.68% |
| Cash Position Ratio | 0.72% | 0.31% | 0.65% | 1.96% |
| Liquididy | 31% | 26% | 38% | 75% |
| Short-term ratios | NAVB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 886.59% | 20.79% | 66.71% | 7.59% |
| Return on assets | -70.31% | 3.25% | 3.83% | 6.92% |
| Return on sales | -4940.46% | 33.05% | 37.56% | 48.89% |
| Return on invested capital | 83.84% | 3.69% | 5.96% | 19.2% |
| Profitability | 50% | 30% | 37% | 56% |
| Total debt ratio | 152.84% | 89.69% | 92.69% | 25.42% |
| Debt ratio change over time | 0.9% | 55.67% | 15.07% | 0.65% |
| Dept financing | 25% | 40% | 22% | 4% |
| Current Ratio | 0.89% | 0.87% | 1.55% | 4.29% |
| Quick Ratio | 0.85% | 0.77% | 1.22% | 3.68% |
| Cash Position Ratio | 0.72% | 0.31% | 0.65% | 1.96% |
| Liquididy | 20% | 14% | 26% | 75% |